Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide

Food and Chemical Toxicology

Volumn 51, Issue 1, 2013, Pages 87-92

  Zhang, Weiqian ^a   Xue, Jiangdong ^b   Ge, Ming ^a   Yu, Meiling ^a   Liu, Lian ^a   Zhang, Zhigang ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Arsenic accumulation; Arsenic trioxide; Liver injury; Oxidative stress; Resveratrol

Indexed keywords

ARSENIC TRIOXIDE; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL VACUOLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATORY CELL; LIVER NECROSIS; LIVER TOXICITY; LONG TERM EXPOSURE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; ARSENIC; ARSENICALS; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIVER; MALE; OXIDATIVE STRESS; OXIDES; RATS; RATS, WISTAR; STILBENES; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 84867237081     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.09.023     Document Type: Article

References (44)

1. Almeida I.M.C., Barreira J.C.M., Oliveira M.B.P.P., Ferreira I.C.F.R. Dietary antioxidant supplements: benefits of their combined use. Food Chem. Toxicol. 2011, 49:3232-3237.
2. Athar M., Back J.H., Tang X.W., Kim K.H., Kopelovich L., Bickers D.R., Kim A.L. Resveratrol: a review of pre-clinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007, 224:274-283.
3. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug. Discov. 2007, 5:493-506.
4. Chen B., Arnold L.L., Cohen S.M., Thomas D.J., Le X.C. Mouse arsenic ({thorn}3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water. Toxicol. Sci. 2011, 124:320-326.
5. Chiou H.Y., Hsueh Y.M., Hsieh L.L., Hsu L.I., Hsu Y.H., Hsieh F.I., Wei M.L., Chen H.C., Yang H.T., Leu L.C., Chu T.H., Chuan C.W., Yang M.H., Chen C.J. Arsenic metyylation capacity, body retention, and null genotypes of glutathione S-tranferase M1 and T1 among current arsenic-exposed residents in Taiwan. Muta. Res-rev. Mutat. 1997, 386:197-207.
6. Csanaky I., Gregus Z. Effect of selenite on the disposition of arsenate and arsenite in rats. Toxicology 2003, 186:33-50.
7. Das A.K., Bag S., Sahu R., Dua T.K., Sinha M.K., Gangopadhyay M., Zaman K., Dewanjee S. Protective effect of Corchorus olitorius leaves on sodium arsenite-induced toxicity in experimental rats. Food Chem. Toxicol. 2010, 48:326-335.
8. Devesa V., Velez D., Montoro R. Effect of thermal treatments on arsenic species contents in food. Food Chem. Toxicol. 2008, 46:1-8.
9. Diaz Z., Colombo M., Mann K.K., Su H.X., Smith K.N., Bohle D.S., Schipper H.M., Miller W.H. Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines. Blood 2005, 105:1237-1245.
10. Dwivedi N., Flora S.J.S. Concomitant exposure to arsenic and organophosphates on tissue oxidative stress in rats. Food Chem. Toxicol. 2011, 49:1152-1159.
11. Fan G., Tang J.J., Bhadauria M., Nirala S.K., Dai F., Zhou B., Li Y., Liu Z.L. Resveratrol ameliorates carbon tetrachloride-induced acute liver injury in mice. Environ. Toxicol. Phar. 2009, 28:350-356.
12. Han D., Hanawa N., Saberi B., Kaplowitz N. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1-G7.
13. Harris G.K., Shi X. Signaling by carcinogenic metals and metal induced reactive oxygen species. Mutat. Res. 2003, 533:183-200.
14. Hayakawa T., Kobayashi Y., Cui X., Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 2005, 79:183-191.
15. Kitchin K.T., Kathleen W. Arsenite binding to synthetic peptides based on the Zn finger region and the estrogen binding region of the human estrogen receptor-a. Toxicol. Appl. Pharmacol. 2005, 206:66-72.
16. Lagouge M., Argmann C., Zachary G.H., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 2006, 127:1109-1122.
17. Leslie E.M. Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs). J. Inorg. Biochem. 2012, 108:141-149.
18. Liang Q.N., Sheng Y.C., Jiang P., Ji L.L., Xia Y.Y., Min Y., Wang Z.T. The difference of glutathione antioxidant system in newly weaned and young mice liver and its involvement in isoline-induced hepatotoxicity. Arch. Toxicol. 2011, 85:1267-1279.
19. Liu J., Liu Y., Goyer R.A., Achanzar W., Waalkes M.P. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci. 2000, 55:460-467.
20. Liu J., Liu Y., Powell D.A., Waalkes M.P., Klaassen C.D. Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. Toxicology 2002, 170:55-62.
21. Lucas-Abellán C., Mercader-Ros M.T., Zafrilla M.P., Gabaldón J.A., Núñez-Delicado E. Comparative study of different methods to measure antioxidant activity of resveratrol in the presence of cyclodextrins. Food Chem. Toxicol. 2011, 49:1255-1260.
22. Johnson W.D., Morrissey R.L., Usborne A.L., Kapetanovic I., Crowell J.A., Muzzio M., McCormick D.L. Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem. Toxicol. 2011, 49:3319-3327.
23. Majhi C.R., Khan S., Leo M.D., Manimaran A., Sankar P., Sarkar S.N. Effects of acetaminophen on reactive oxygen species and nitric oxide redox signaling in kidney of arsenic-exposed rats. Food Chem. Toxicol. 2011, 49:974-982.
24. Neves R.N.D., Carvalho F., Carvalho M., Fernandes E., Soares E., Basto M.D.L., Pereira M.D.L. Protective activity of hesperidin and lipoic acid against sodium arsenite acute toxicity in mice. Toxicol. Pathol. 2004, 32:527-535.
25. Patra P.H., Bandyopadhyay S., Kumar R., Datta B.K., Maji C., Biswas S., Dash J.R., Sar T.K., Sarkar S., Manna S.K., Chakraborty A.K., Mandal T.K. Quantitative imaging of arsenic and its species in goat following long term oral exposure. Food Chem. Toxicol. 2012, 50:1946-1950.
26. Paul M.K., Kumar R., Mukhopadhyay A.K. Dithothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular caricinoma cells. Toxicol. Appl. Pharmacol. 2007, 226:140-152.
27. Plaa G., Charbonneau M. Detection and evaluation of chemically induced liver injury. Principles and Methods of Toxicology 1994, 841. Raven Press, New York. A.W. Hayes (Ed.).
28. Rao J.P. The other side of arsenic. Al Ameen J. Med. Sci. 2009, 2:51-56.
29. Ricardo V.B., Sorribas V. Arsenate transport by sodium/phosphate cotransporter type IIb. Toxicol. Appl. Pharmacol. 2010, 247:36-40.
30. Roy M., Sinha D., Mukherjee S., Paul S., Bhattacharya R.K. Protective effect of dietary phytochemicals against arsenite induced genotoxicity in mammalian V79 cells. Indian J. Exp. Biol. 2008, 46:690-697.
31. Sahar H.K., Cottart C.H., Wendum D., Vibert F., Clot J.P., Savouret J.F., Conti M., Valerie N.A. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery. Liver Transplant 2008, 14:451-459.
32. Schuliga M., Chouchane S., Snow E.T. Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol. Sci. 2002, 70:183-192.
33. Sener G., Toklu H.Z., Sehirli A.O., Velioĝlu-Oĝünç A., Cetinel S., Gedik N. Protective effects of resveratrol against acetaminophen-induced toxicity in mice. Hepatol. Res. 2006, 35:62-68.
34. Shankar S., Singh G., Srivastava R.K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 2007, 12:4839-4854.
35. Spyros K.S., Christopher J.B., Sastry S.I., Panos G.G. Mathematical model of uptake and metabolism of arsenic(III) in human hepatocytes - Incorporation of cellular antioxidant response and threshold-dependent behavior. BMC. Syst. Biol. 2011, 5:16.
36. Thomas D.J., Waters S.B., Styblo M. Elucidating the pathway for arsenic methylation. Toxicol. Appl. Pharmacol. 2004, 198:319-326.
37. Upadhyay G., Singh A.K., Kumar A., Prakash O., Singh M.P. Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur. J. Pharmacol. 2008, 596:146-152.
38. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 2000, 112-113:209-217.
39. Vieira C., Morais S., Ramos S., Delerue-Matos C., Oliveira M.B. Mercury, cadmium, lead and arsenic levels in three pelagic fish species from the Atlantic Ocean: intra- and inter-specific variability and human health risks for consumption. Food Chem. Toxicol. 2011, 49:923-932.
40. Yang S.H., Kim J.S., Oh T.J., Kim M.S., Lee S.W., Woo S.K., Cho H.S., Choi Y.H., Kim Y.H., Rha S.Y., Chung H.C., An S.W. Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int. J. Oncol. 2003, 22:741-750.
41. Yokohira M., Arnold L.L., Pennington K.L., Suzuki S., Satoko K.K., Karen H.D., Thomas D.J., Cohen S.M. Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia induced by arsenite in arsenic (+3 oxidation state) methyltransferase knockout mice. A preliminary report. Toxicol. Appl. Pharmacol. 2010, 246:1-7.
42. Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B., Liang W.X., Song A.X., Valérie L.B., Jeanne M., Zhang Q.Y., Yang H.Y., Huang Q.H., Zhou G.B., Tong J.H., Zhang Y., Wu J.H., Hu H.Y., Hugues D.T., Chen S.J., Chen Z. Arsenic trioxide controls the fate of the PML-RARa oncoprotein by directly binding PML. Science 2010, 328:240-243.
43. Zhao X.Y., Li G.Y., Liu Y., Chai L.M., Chen J.X., Zhang Y., Du Z.M., Lu Y.J., Yang B.F. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Brit. J. Pharmacol. 2008, 154:105-113.
44. 3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism. Blood 2005, 105:1198-1203.